Linda Anne Feagins MD FACP, AGAF, FACP

Gastroenterology•Austin, TX

Inflammatory Bowel Disease

Professor, Internal Medicine, University of Texas at Austin, Dell Medical School and Director, Center for Inflammatory Bowel Diseases at Dell Medical School

Join to View Full Profile

1601 Trinity Street, Ste. 9.901SAustin, TX 78712
Phone+1 512-324-9660

Education & Training

University of Texas Southwestern Medical CenterFellowship, Gastroenterology, 2003 - 2007
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2001 - 2003
Baylor College of MedicineClass of 2001
Vanderbilt UniversityBE, Biomedical Engineering, Magna Cum Laude, 1993 - 1997

Certifications & Licensure

TX State Medical License 2003 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology
American Board of Internal MedicineMedicine

Clinical Trials

Exacerbating Factors in Inflammatory Bowel Disease Start of enrollment: 2009 Aug 01
Completed
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis Start of enrollment: 2012 Jun 01
Unknown status
Phase 2
Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping Start of enrollment: 2011 Sep 01
Completed
Not Applicable
CorEvitas Inflammatory Bowel Disease (IBD) Registry Start of enrollment: 2017 Mar 27
RECRUITING
Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis Start of enrollment: 2019 Jun 13
Completed
Phase 3
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Start of enrollment: 2019 Sep 05
ACTIVE_NOT_RECRUITING
PHASE3
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis Start of enrollment: 2020 Sep 15
Completed
Phase 3
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease Start of enrollment: 2020 Jan 06
RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Delayed Corticosteroid Treatment for Patients Requiring Hospitalization for Acute Inflammatory Bowel Disease Exacerbations Increases Length of Stay and Risk for Surger...
Jaya Vasudevan, Bhuvana Mukkamala, Bani Dhother, Paul Guzik, Zhouwen David Tang
Digestive Diseases and Sciences. 2025-03-01
Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapies Linked to Insurance Delays, Intravenous Infusions, and Lack of Pharmacy Support.
Sara Gottesman, Karen Xiao, Hang P Nguyen, Elizabeth Hernandez, Emily Saweris
Clinical and Translational Gastroenterology. 2025-03-01
Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease.
Linda A Feagins, Page Moore, Margaux M Crabtree, Melissa Eliot, Celeste A Lemay
Crohn's & Colitis 360. 2025-01-01

Authored Content

Colonoscopy, Polypectomy, and the Risk of BleedingNovember 2018
Tu1054 LOW RATES OF REBLEEDING FOR PATIENTS WHO EXPERIENCE POST-POLYPECTOMY BLEEDINGMay 2018

Press Mentions

Why Diet Absolutely Matters in Ulcerative ColitisApril 20th, 2023
Clinical Challenges: Integrating Diet into Crohn's Disease ManagementDecember 29th, 2023
Clinical Challenges: Integrating Nutrition into the Treatment of Crohn’s DiseaseDecember 31st, 2023

Committees

Member, CCFA Patient Education Committee 2008 - Present

Professional Memberships

American College of Gastroenterology - ACG
Member
American Gastroenterological Association - AGA
Member
American Society for Gastrointestinal Endoscopy - ASGE
Member
Crohn's and Colitis Foundation of America
Member
American College of Physicians - ACP
Member